Abstract
Background Storage time influence concentration levels of blood biomarker. This study aimed to assess the effect of water intake prior sampling and storage time on protein concentration, enzyme AChE activity, inhibitor efficacy and to build an efficient inhibitor calibration curve in healthy individuals.
Methods Data analysis was performed on 11 participants. Study utilizes substrate acetylcholine chloride and inhibitors BW284c51 (0.01mM) and GUK-987 (0.1mM). Calibration curve ranging from 10-1 to 10-38 mM was build for inhibitor GUK-987 and GDK-510.
Data analysis is carried out with Microsoft Excel 2007. Data analysis was performed via IBM SPSS Statistical Software v23.0. Descriptive statistics and parametric statistical tests were assessed for 0, 90, 91 and 92 days of storage in Plasma and Erythrocyte samples. Workflow of building calibration curve and the most efficient inhibition concentration is assessed.
Results Water intake and storage time have effect on in vitro protein concentration, activation/inhibition of enzyme AChE activity in Plasma and Erythrocyte samples. However, 100% inhibitor efficacy is maintained for inhibitor GUK-987 in Plasma samples and inhibitor BW284c51 in Erythrocyte samples. The most efficient inhibitor concentration is determined.
Conclution Significant changes and variable association have been estimated between protein concentration, activation/inhibition of enzyme AChE activity, as a cause of water intake and storage time. Taking all these factors into account for further research is important for disease prevention and human wellbeing.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There have been no sources of funding for this type of research. This research is done as a part of PhD thesis through CEEPUS freemover mobility of University of Belgrade, Serbia with University of Ljubljana, Biotechnical Faculty, Slovenia, mentoring of prof. dr. Damjana Drobne and proximate collaboration on an international project J5-7098 Assessment of blood parameters and extracellular vesicles for optimisation of sport results, PI Veronika Kralj-Iglic.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Experiments were performed according to ethical standards and with written consent of the blood donors. The study was given ethical permission from the National Medical Ethics Committee (number 82/07/14). Experimental part of the experiment was done at the Biotechnical Faculty, University of Ljubljana, Slovenia, within the project J5-7098 and CEEPUS free mover PhD student program mobility with the University of Belgrade, Serbia.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data available from Table 1
List of abbreviations
- A AChE
- Acetilcholine esterase, (sinonim: blood, erythrocyte cholinesterase)
- B BChE
- Butyrylcholinesterase (sinonim: plasmatic, pseudocholinesterase)
- C ChE
- Cholinesterase enzymes
- C
- Control
- E ER
- Erythrocites
- F FDA
- Food Drug Agency
- L LE
- Leucocyte
- P PL
- Plasma
- Pt
- Platelet
- T T
- Test
- W WB
- Whole blood
